Related Experiment Video
Updated: Jan 27, 2026

Rat Burn Model to Study Full-Thickness Cutaneous Thermal Burn and Infection
Published on: August 23, 2022
Mucormycosis in Burn Patients
Pauline Devauchelle1, Mathieu Jeanne2,3, Emilie Fréalle4,5
1CHU Lille, Centre des Brûlés, F-59000 Lille, France. pauline.clementgrandcourt@chru-lille.fr.
Abstract:
Patients with extensive burns are an important group at risk for cutaneous mucormycosis. This study aimed to perform a systematic review of all reported mucormycosis cases in burn patients from 1990 onward. A Medline search yielded identification of 7 case series, 3 outbreaks, and 25 individual cases reports. The prevalence reached 0.04%⁻0.6%. The median age was 42⁻48 in the case series and outbreaks, except for the studies from military centers (23.5⁻32.5) and in individual reports (29.5). The median total body surface area reached 42.5%⁻65%. Various skin lesions were described, none being pathognomonic: the diagnosis was mainly reached because of extensive necrotic lesions sometimes associated with sepsis. Most patients were treated with systemic amphotericin B or liposomal amphotericin B, and all underwent debridement and/or amputation. Mortality reached 33%⁻100% in the case series, 29%⁻62% during outbreaks, and 40% in individual cases. Most patients were diagnosed using histopathology and/or culture. Mucorales qPCR showed detection of circulating DNA 2⁻24 days before the standard diagnosis. Species included the main clinically relevant mucorales (i.e., Mucor, Rhizopus, Absidia/Lichtheimia, Rhizomucor) but also more uncommon mucorales such as Saksenaea or Apophysomyces. Contact with soil was reported in most individual cases. Bandages were identified as the source of contamination in two nosocomial outbreaks.
Insights
Cutaneous mucormycosis is a serious risk for burn patients, with high mortality rates. Early diagnosis using Mucorales qPCR may improve outcomes for this vulnerable population.
Area of Science:
- Mycology
- Infectious Diseases
- Burn Care
Background:
- Patients with extensive burns are susceptible to opportunistic fungal infections.
- Cutaneous mucormycosis presents a significant challenge in burn wound management.
- Limited data exists on the epidemiology and clinical characteristics of mucormycosis in burn patients.
Purpose of the Study:
- To systematically review reported cases of cutaneous mucormycosis in burn patients from 1990 onwards.
- To analyze the prevalence, clinical features, diagnostic methods, treatment, and outcomes.
- To identify risk factors and potential sources of infection.
Main Methods:
- Systematic literature search of Medline for case series, outbreaks, and individual case reports of mucormycosis in burn patients since 1990.
- Data extraction on patient demographics, burn characteristics, clinical presentation, diagnostic methods, treatments, and outcomes.
- Analysis of prevalence, mortality rates, and causative fungal species.
Main Results:
- The review identified 7 case series, 3 outbreaks, and 25 individual case reports.
- Prevalence ranged from 0.04% to 0.6%, with high mortality (33%-100%).
- Diagnosis often relied on extensive necrotic lesions and sepsis; Mucorales qPCR detected DNA earlier than standard methods.
Conclusions:
- Cutaneous mucormycosis in burn patients is associated with high mortality.
- Early diagnosis, potentially aided by Mucorales qPCR, and aggressive management including debridement are crucial.
- Nosocomial transmission via bandages and environmental exposure (soil) are potential sources.
More Related Videos
Related Concept Videos
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Patient-centered Care
Drug Dosing: Obese Patients
Drug Dosing: Geriatric Patients
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

